George M. Savage
Fundador en Proteus Digital Health, Inc. .
Cargos activos de George M. Savage
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Director Técnico/Científico/I+D | 02/09/2009 | - |
Fundador | 01/01/2001 | - | |
Corporate Officer/Principal | 01/07/2001 | 02/09/2009 |
Historial de carrera de George M. Savage
Antiguos cargos conocidos de George M. Savage.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Spring Ridge Ventures
Spring Ridge Ventures Investment ManagersFinance Spring Ridge Ventures (Spring Ridge Ventures) is a venture capital firm founded in 2000 by George M. Savage and Andrew Thompson. The firm is headquartered in Menlo Park, California. | Director de Inversiones | 01/01/2000 | 31/01/2021 |
Fundador | 17/11/2010 | 31/01/2021 | |
Inversor de Capital Privado | 17/11/2010 | 31/01/2021 | |
FemRx, Inc.
FemRx, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, FemRx, Inc. is a company that produces medical products for gynecological disorders. The company is based in Sunnyvale, CA. FemRx was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million. | Corporate Officer/Principal | - | - |
CardioRhythm
CardioRhythm Medical SpecialtiesHealth Technology Part of Medtronic Plc, CardioRhythm is a company that manufactures electrophysiological catheters. The company is based in San Jose, CA. CardioRhythm was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on May 26, 1992. | Corporate Officer/Principal | - | - |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - | - |
Formación de George M. Savage.
Boston University | Undergraduate Degree |
Stanford University | Masters Business Admin |
Tufts University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Israel | 2 |
Operativa
Corporate Officer/Principal | 4 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Health Technology |
Spring Ridge Ventures
Spring Ridge Ventures Investment ManagersFinance Spring Ridge Ventures (Spring Ridge Ventures) is a venture capital firm founded in 2000 by George M. Savage and Andrew Thompson. The firm is headquartered in Menlo Park, California. | Finance |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
CardioRhythm
CardioRhythm Medical SpecialtiesHealth Technology Part of Medtronic Plc, CardioRhythm is a company that manufactures electrophysiological catheters. The company is based in San Jose, CA. CardioRhythm was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on May 26, 1992. | Health Technology |
FemRx, Inc.
FemRx, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, FemRx, Inc. is a company that produces medical products for gynecological disorders. The company is based in Sunnyvale, CA. FemRx was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million. | Health Technology |
- Bolsa de valores
- Insiders
- George M. Savage
- Experiencia